Indication
Adults, adolescents (12 years and over) and children (6-11 years). Avamys is indicated for the treatment of the symptoms of allergic rhinitis.
Loading your page…
Loading your page…
Rhinitis, Allergic, Seasonal;Rhinitis, Allergic, Perennial
Marketing Authorisation Holder: GlaxoSmithKline Trading Services Limited
EMA Authorisation: 11/01/2008
INN: fluticasone furoate
AI Drug & Interaction Analysis
Free account required
Ask Osler about Avamys: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.